{
    "2018-12-12": [
        [
            {
                "time": "",
                "original_text": "天坛生物2018三季报点评:血液制品资产整合顺利",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "三季报",
                        "血液制品",
                        "资产整合"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}